NEWMARKET CORP
NEUNYSEMaterials · Industrial Organic Chemicals · VA · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.73B | $2.79B | $2.70B | $2.76B | $2.36B | $2.01B |
| Operating income | $543.7M | $590.0M | $483.0M | $355.1M | $257.8M | $311.8M |
| Net income | $418.7M | $462.4M | $388.9M | $279.5M | $190.9M | $270.6M |
| Total assets | $3.49B | $3.13B | $2.31B | $2.41B | $2.56B | $1.93B |
| Total liabilities | $1.71B | $1.67B | $1.23B | $1.64B | $1.80B | $1.17B |
| Equity | $1.78B | $1.46B | $1.08B | $762.4M | $762.1M | $759.8M |
| EPS (diluted) | $44.44 | $48.22 | $40.44 | $27.77 | $17.71 | $24.64 |
| Shares out. | 9.5M | 9.6M | 9.7M | 10.3M | 10.9M | 11.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 20.0%
- Net margin
- 15.4%
- Return on equity
- 23.5%
- Return on assets
- 12.0%
- Return on capital (ROCE)
- 17.7%
- Liabilities / assets
- 49.1%
- Debt / equity
- 0.96×
- Book value / share
- $186.70
- Revenue growth (YoY)
- −2.2%
- Net income growth (YoY)
- −9.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 4.90safe
- Accruals / assets
- −4.3%clean
- Beneish M-Score
- -2.56normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 6 good- Revenue declined year-over-year
- Operating margin is positive
- Strong return on equity (>15%)
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Bank Of America Corp /De/Passive (13G)May 14, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Gottwald Bruce CActivist (13D)Jan 7, 2026
- London Co Of VirginiaPassive (13G)Aug 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 689,467 | 8.3 | +20.9% |
| Apr 30, 2026 | 570,259 | 4.3 | +10.3% |
| Apr 15, 2026 | 517,102 | 4.5 | -3.9% |
| Mar 31, 2026 | 537,808 | 3.8 | -12.9% |
| Mar 13, 2026 | 617,168 | 3.6 | +31.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder vote · Other material eventApr 23, 2026
- Results of operationsApr 22, 2026
- Other material eventFeb 26, 2026
- Director / officer changeFeb 26, 2026
- Director / officer changeFeb 18, 2026
- Results of operationsFeb 11, 2026
- Director / officer changeDec 9, 2025
- Director / officer changeNov 5, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 11-KFORM 11-KMay 18, 2026
- SCHEDULE 13G/AMay 14, 2026
- 8-KApr 23, 2026
- 10-QApr 23, 2026
- 8-KApr 22, 2026
- SCHEDULE 13G/AMar 27, 2026
- ARSMar 12, 2026
- DEFA14AMar 12, 2026
- DEF 14AMar 12, 2026
- 8-KFeb 26, 2026
- 8-KFeb 26, 2026
- 4Feb 25, 2026
- 3Feb 20, 2026
- 4Feb 20, 2026
- 4Feb 20, 2026